Personal information

No personal information available

Activities

Collapse all

Works (33)

Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma

Clinical Cancer Research
2025-02-24 | Journal article
DOI: 10.1158/1078-0432.CCR-24-1228
Contributors: Sung Won Chung; Jin Sun Kim; Won-Mook Choi; Jonggi Choi; Danbi Lee; Ju Hyun Shim; Young-Suk Lim; Han Chu Lee; Kang Mo Kim
Source: check_circle
Crossref

Risk of Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab Treatment for Hepatocellular Carcinoma

Alimentary Pharmacology & Therapeutics
2025-01-28 | Journal article
DOI: 10.1111/apt.18526
Contributors: Kanghee Park; Hye Won Lee; Euichang Kim; Won‐Mook Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young‐Suk Lim; Han Chu Lee; Changhoon Yoo et al.
Source: check_circle
Crossref

Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study

American Journal of Gastroenterology
2024-12-24 | Journal article
DOI: 10.14309/ajg.0000000000003261
Contributors: Sung Won Chung; Ye-Jee Kim; Jihye Lim; Jonggi Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Sehee Kim et al.
Source: check_circle
Crossref

Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability

Journal of Gastroenterology and Hepatology
2024-10 | Journal article
DOI: 10.1111/jgh.16656
Contributors: Jiwon Yang; Won‐Mook Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young‐Suk Lim; Han Chu Lee; Jonggi Choi
Source: check_circle
Crossref

Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma

Liver Cancer
2024-10-16 | Journal article
DOI: 10.1159/000541621
Contributors: Jiwon Yang; Won-Mook Choi; Hyung-Don Kim; Jonggi Choi; Changhoon Yoo; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee
Source: check_circle
Crossref

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma

Journal of Liver Cancer
2024-09-30 | Journal article
DOI: 10.17998/jlc.2024.03.25
Contributors: Jiwon Yang; Won-Mook Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Deok-Bog Moon; Dong-Hwan Jung; Jonggi Choi
Source: check_circle
Crossref

Improving the hepatitis C virus care cascade with the in‐hospital Reflex tEsting ALarm‐C (REAL‐C) model

Liver International
2024-05 | Journal article
DOI: 10.1111/liv.15877
Contributors: Jonggi Choi; Jina Park; Won‐Mook Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young‐Suk Lim; Han Chu Lee; Sujin Kwon; Sang‐Hyun Hwang
Source: check_circle
Crossref

Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC

Liver International
2024-04 | Journal article
DOI: 10.1111/liv.15826
Contributors: Jiwon Yang; Jonggi Choi; Won‐Mook Choi; Kang Mo Kim; Han Chu Lee; Ju Hyun Shim
Source: check_circle
Crossref

Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial

Nature Medicine
2024-03 | Journal article
DOI: 10.1038/s41591-024-02824-y
Contributors: Hyung-Don Kim; Seyoung Jung; Ho Yeong Lim; Baek-Yeol Ryoo; Min-Hee Ryu; Samuel Chuah; Hong Jae Chon; Beodeul Kang; Jung Yong Hong; Han Chu Lee et al.
Source: check_circle
Crossref

Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment

Alimentary Pharmacology & Therapeutics
2024-02 | Journal article
DOI: 10.1111/apt.17819
Contributors: Hyeyeon Hong; Minjoo Cho; Chaeyeon Lim; Won‐Mook Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young‐Suk Lim; Han Chu Lee; Jonggi Choi
Source: check_circle
Crossref

Prediction of Hepatocellular Carcinoma Development in Korean Patients after Hepatitis C Cure with Direct-Acting Antivirals

Gut and Liver
2024-01-15 | Journal article
DOI: 10.5009/gnl220386
Contributors: Hyeyeon Hong; Won-Mook Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Jonggi Choi
Source: check_circle
Crossref

Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment

Journal of Liver Cancer
2023-03-31 | Journal article
DOI: 10.17998/jlc.2023.03.04
Contributors: Sujin Jin; Won-Mook Choi; Ju Hyun Shim; Danbi Lee; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Jinhong Jung; Sang Min Yoon; Jonggi Choi
Source: check_circle
Crossref

Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study

Liver Cancer
2022 | Journal article
DOI: 10.1159/000518837
Contributors: Ha Il Kim; Jihyun An; Ji Yoon Kim; Hyun Phil Shin; Seo Young Park; Gi-Won Song; Han Chu Lee; Ju Hyun Shim
Source: check_circle
Crossref

Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and Radiotherapy

Liver Cancer
2022 | Journal article
DOI: 10.1159/000521227
Contributors: Jinhong Jung; Ji Hyeon Joo; So Yeon Kim; Jin Hyoung Kim; Jonggi Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee et al.
Source: check_circle
Crossref

Treatment patterns for hepatocellular carcinoma in patients with Child–Pugh class B and their impact on survival: A Korean nationwide registry study

Liver International
2022-12 | Journal article
DOI: 10.1111/liv.15464
Contributors: Dongsub Jeon; Gi‐Won Song; Han Chu Lee; Ju Hyun Shim
Source: check_circle
Crossref

The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment

Gut and Liver
2022-11-15 | Journal article
DOI: 10.5009/gnl210416
Contributors: Jonggi Choi; Jina Park; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa Chung
Source: check_circle
Crossref

Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study

Journal of Viral Hepatitis
2022-09 | Journal article
DOI: 10.1111/jvh.13721
Contributors: Jihye Lim; Jung‐Bok Lee; Jihyun An; Gi‐Won Song; Kang Mo Kim; Han Chu Lee; Ju Hyun Shim
Source: check_circle
Crossref

Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study

Journal of Liver Cancer
2022-09-30 | Journal article
DOI: 10.17998/jlc.2022.08.18
Contributors: Jeong Yun Jang; Jinhong Jung; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Jin-hong Park; Sang Min Yoon
Source: check_circle
Crossref

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis B

Liver International
2022-07 | Journal article
DOI: 10.1111/liv.15261
Contributors: Jihye Lim; Won‐Mook Choi; Ju Hyun Shim; Danbi Lee; Kang Mo Kim; Young‐Suk Lim; Han Chu Lee; Jonggi Choi
Source: check_circle
Crossref

Identification of hepatic steatosis in living liver donors by machine learning models

Hepatology Communications
2022-07 | Journal article
DOI: 10.1002/hep4.1921
Contributors: Jihye Lim; Seungbong Han; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young‐Suk Lim; Han Chu Lee; Dong Hwan Jung; Sung‐Gyu Lee; Ki‐Hun Kim et al.
Source: check_circle
Crossref

The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma

Journal of Liver Cancer
2022-03-31 | Journal article
DOI: 10.17998/jlc.2022.03.06
Contributors: Jihyun An; Hyo Jeong Kang; Eunsil Yu; Han Chu Lee; Ju Hyun Shim
Source: check_circle
Crossref

Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study

Liver Cancer
2021 | Journal article
DOI: 10.1159/000512781
Contributors: Changhoon Yoo; Jwa Hoon Kim; Min-Hee Ryu; Sook Ryun Park; Danbi Lee; Kang Mo Kim; Ju Hyun Shim; Young-Suk Lim; Han Chu Lee; Joycelyn Lee et al.
Source: check_circle
Crossref

Prospective Multi-Center Korean Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolics for Nodular Hepatocellular Carcinoma: A Two-Year Outcome Analysis

Korean Journal of Radiology
2021 | Journal article
DOI: 10.3348/kjr.2020.1117
Contributors: Myungsu Lee; Jin Wook Chung; Kwang-Hun Lee; Jong Yun Won; Ho Jong Chun; Han Chu Lee; Jin Hyoung Kim; In Joon Lee; Saebeom Hur; Hyo-Cheol Kim et al.
Source: check_circle
Crossref

Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma

Liver International
2021-09 | Journal article
DOI: 10.1111/liv.14932
Contributors: Won‐Mook Choi; Ji Yoon Kim; Jonggi Choi; Danbi Lee; Ju Hyun Shim; Young‐Suk Lim; Han Chu Lee; Changhoon Yoo; Min‐Hee Ryu; Baek‐Yeol Ryoo et al.
Source: check_circle
Crossref

Radiofrequency ablation versus stereotactic body radiation therapy for small (≤ 3 cm) hepatocellular carcinoma: A retrospective comparison analysis

Journal of Gastroenterology and Hepatology
2021-07 | Journal article
DOI: 10.1111/jgh.15442
Contributors: Yuri Jeong; Kyung Jin Lee; So Jung Lee; Yong Moon Shin; Min‐Ju Kim; Young‐Suk Lim; Han Chu Lee; Jinhong Jung; Jin‐hong Park; Jong Hoon Kim et al.
Source: check_circle
Crossref

Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

Liver Cancer
2020 | Journal article
DOI: 10.1159/000508901
Contributors: Jaekyung Cheon; Hong Jae Chon; Yeonghak Bang; Neung Hwa Park; Jung Woo Shin; Kang Mo Kim; Han Chu Lee; Jooho Lee; Changhoon Yoo; Baek-Yeol Ryoo
Source: check_circle
Crossref

In reply to Huo et al.: Treating small hepatocellular carcinoma: Stereotactic body radiation therapy versus radiofrequency ablation

Journal of Gastroenterology and Hepatology
2020-12 | Journal article
DOI: 10.1111/jgh.15250
Contributors: S Park; J Jung; B Cho; SY Kim; S‐C Yun; Y‐S Lim; HC Lee; J Park; J‐h Park; JH Kim et al.
Source: check_circle
Crossref

Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma

Journal of Gastroenterology and Hepatology
2020-11 | Journal article
DOI: 10.1111/jgh.15011
Contributors: Sunmin Park; Jinhong Jung; Byungchul Cho; So Yeon Kim; Sung‐Cheol Yun; Young‐Suk Lim; Han Chu Lee; Jongmoo Park; Jin‐hong Park; Jong Hoon Kim et al.
Source: check_circle
Crossref

Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study

Gut and Liver
2020-03-15 | Journal article
DOI: 10.5009/gnl19005
Contributors: Joon Yeul Nam; Eun Sun Jang; Young Seok Kim; Youn Jae Lee; In Hee Kim; Sung Bum Cho; Han Chu Lee; Si Hyun Bae; Moran Ki; Hwa Young Choi et al.
Source: check_circle
Crossref

Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma

PLOS ONE
2020-03-04 | Journal article
DOI: 10.1371/journal.pone.0229696
Contributors: Jonggi Choi; Gregory Tiao; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Yung Sang Lee; Han Chu Lee
Source: check_circle
Crossref

Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study

Liver Cancer
2019 | Journal article
DOI: 10.1159/000488541
Contributors: Hyo Jeong Kang; Farhan Haq; Chang Ohk Sung; Jene Choi; Seung-Mo Hong; Soo-Heang Eo; Hui Jeong Jeong; Jinho Shin; Ju Hyun Shim; Han Chu Lee et al.
Source: check_circle
Crossref

Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study

Hepatology International
2019-11-05 | Journal article
DOI: 10.1007/s12072-019-09994-9
Contributors: Yeonjung Ha; Tae Hun Kim; Jae Eul Shim; Sunghyun Yoon; Mi Jung Jun; Young-Ho Cho; Han Chu Lee
Source: check_circle
Crossref

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection

PLOS ONE
2018-06-07 | Journal article
DOI: 10.1371/journal.pone.0198138
Contributors: Seong Kyun Na; Heather Francis; Gwang Hyeon Choi; Han Chu Lee; Yong Moon Shin; Jihyun An; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim et al.
Source: check_circle
Crossref
How many people are using ORCID?